(Teleborsa) – The risk of exposure to COVID-19 while traveling, after all passengers turn out test negative carried out 72 hours before the flight, is less than 0.1%. This is what one reveals exclusive studio which took into consideration the real data of the passengers present on the Delta’s COVID-tested flights between New York-JFK, Atlanta and Rome Fiumicino International Airport in Italy.
The study published in Mayo Clinic Proceedings proved that a single COVID-19 molecular test performed within 72 hours from the start could decrease the rate of actively infected people aboard a commercial aircraft at a level that is significantly lower than community infection rates. For example, when the community’s median infection rate was 1.1 percent, infection rates on COVID-tested flights were 0.05 percent. The Georgia Department of Health and the Mayo Clinic conducted the study in collaboration with Delta.
“The risk of air travel varies with case rates and vaccination rates at origin and destination, mask use and other factors. – explained the doctor Henry Ting, Delta’s Chief Health Officer – But the data collected from this study shows that the routine use of a single molecular test within 72 hours prior to international travel for unvaccinated individuals significantly mitigates the risk of COVID exposure and transmission- 19 during air travel “.
The study is started in December 2020 con the program COVID-tested transatlantic flights which allowed entry into Italy without quarantine and allowed teams to examine and model various testing strategies for feasibility, false positive rates, and case detection rates